Kiniksa Pharmaceuticals International, plc (KNSA) stock
KNSANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 27, 2026Score 14/30469% above fair value
$95.11+0.88 (+0.93%)
Close on Nov 17, 2026Market cap $14.95BP/E 73.2Yield –
Kiniksa Pharmaceuticals International price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Kiniksa Pharmaceuticals International's price to book ratio was 12.0× on Nov 11, 2026, against 6.1× a year earlier. Over the last 5 years it ranged from 1.9× to 12.0×, with a median of 3.8×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 12.0× | +6.1 |
| 2025 | Dec 31, 2025 | 5.9× | +2.6 |
| 2024 | Dec 31, 2024 | 3.3× | +0.2 |
| 2023 | Dec 29, 2023 | 3.1× | +0.3 |
| 2022 | Dec 30, 2022 | 2.7× | −1.0 |
| 2021 | Dec 31, 2021 | 3.8× | +0.9 |
| 2020 | Dec 31, 2020 | 2.9× | +0.6 |
| 2019 | Dec 31, 2019 | 2.3× | +0.7 |
| 2018 | Dec 31, 2018 | 1.6× | – |
See a number that looks wrong?